Company Performance: VIRI.PA's financial health, revenue, profit margins, and overall growth significantly influence its stock price. Positive performance generally leads to higher stock valuation.

Industry Trends: The performance of the broader pharmaceutical and biotechnology sector impacts investor sentiment towards VIRI.PA. Upward trends in the industry can positively affect the stock.

Clinical Trial Results: As a pharmaceutical company, VIRI.PA's stock is highly sensitive to the outcomes of its clinical trials. Successful trials typically boost the stock price, while failures can cause significant declines.

Regulatory Approvals: Approval of VIRI.PA's drugs by regulatory bodies like the EMA is a crucial driver. Positive decisions usually lead to increased investor confidence and higher stock prices.

Market Sentiment: General market conditions, investor psychology, and global economic factors all play a role. Bullish markets tend to lift most stocks, while bearish markets can drag them down.

Competition: The competitive landscape within the pharmaceutical industry, including the emergence of new drugs or technologies, can affect VIRI.PA's market share and, consequently, its stock price.

Economic Factors: Macroeconomic conditions such as interest rates, inflation, and currency exchange rates can indirectly influence VIRI.PA's stock price by impacting overall investor behavior and capital flows.

News and Events: Major news announcements, company press releases, and unforeseen events can create volatility in VIRI.PA's stock price as investors react to new information.

Analyst Ratings: Investment analysts' ratings and price targets can influence investor perceptions. Upgrades often lead to price increases, while downgrades can result in price declines.